Dineo Khabele

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer”.

Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer

Scientific Reports(2020)10.1038/s41598-020-68639-2

N/A

0DataRank · unranked

47 citations

Allison Young, Carlysa Oyama, Alejandro ClaureDeLaZerda, Yueying Liu, Matthew J. Ravosa +5 more

Disparities in ovarian cancer survival at the only NCI-designated cancer center in Kansas

The American Journal of Surgery(2020)10.1016/j.amjsurg.2020.12.009

N/A

0DataRank · unranked

16 citations

Parmida Shahiri, Andrea Jewell, Lori Spoozak, Julia Chapman, Sharon Fitzgerald Wolff +3 more

Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis

Biomarker Research(2020)10.1186/s40364-020-00227-y

N/A

0DataRank · unranked

11 citations

Andrew J. Wilson, Jamie A. Saxon, Timothy S. Blackwell, Jaclyn C. Watkins, Dineo Khabele +4 more

CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.01.038

N/A

0DataRank · unranked

42 citations

Andrew J. Wilson, Jeff Hirst, Katherine F. Roby, Oluwole Fadare, Marta A. Crispens +3 more

Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer

BMC Cancer(2020)10.1186/s12885-020-07450-8

N/A

0DataRank · unranked

32 citations

Demetra Hufnagel, Whitney R. Harris, Kennady K. Bullock, Evan B. Glass, Esther Liu +7 more

Increasing Area Deprivation Index negatively impacts ovarian cancer survival

Cancer Epidemiology(2021)10.1016/j.canep.2021.102013

N/A

0DataRank · unranked

47 citations

Dineo Khabele, Fiona E. Yull, Pamela C. Hull, Joellen M. Schildkraut, Marta A. Crispens +2 more

Impact of employment and insurance status on distress in gynecologic oncology patients

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.038

N/A

0DataRank · unranked

10 citations

David H. Morris, Molly M. Greenwade, Megan Landon, Andrea R. Hagemann, Premal H. Thaker +8 more

Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

Cancers(2021)10.3390/cancers13235877

N/A

0DataRank · unranked

7 citations

Elena Lomonosova, Shaina F. Bruce, Joan Tankou, Mary M. Mullen, Angela M. Schab +12 more

Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100808

N/A

0DataRank · unranked

3 citations

Jennifer Stanley, Michael Toboni, Julie K. Schwarz, F. Zhang, Andrea R. Hagemann +8 more

CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

Cancer(2022)10.1002/cncr.34582

N/A

0DataRank · unranked

46 citations

Ashley Weir, Nicola S. Meagher, Kyo Farrington, Gregg Nelson, Prafull Ghatage +95 more

Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer

BMC Cancer(2022)10.1186/s12885-022-09612-2

N/A

0DataRank · unranked

32 citations

Alyssa Hoover, Kennady K. Bullock, Matthew Z. Madden, Bradley I. Reinfeld, Whitney R. Harris +10 more

GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0704

N/A

0DataRank · unranked

16 citations

Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth Stock, Alyssa Oplt +13 more

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101075

N/A

0DataRank · unranked

1 citations

Angela L. Mazul, Christine Marx, Mary M. Mullen, Molly M. Greenwade, L. Stewart Massad +9 more

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3335

N/A

0DataRank · unranked

65 citations

Lillian N. van Biljon, Mark C. Valentine, Alba Llop‐Guevara, Emily Graham, Bisiayo Fashemi +18 more

Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0347

N/A

0DataRank · unranked

22 citations

Molly M. Greenwade, Elizabeth Stock, Elena Lomonosova, Kevin Cho, Whitney R. Grither +17 more

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Journal of Visualized Experiments(2023)10.3791/65068

N/A

0DataRank · unranked

12 citations

Lillian van Biljon, Jeimmy Rodriguez, Olivia Graham, Mary P. Mullen, Dineo Khabele +1 more

Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer

Cell Death and Disease(2024)10.1038/s41419-024-06717-3

N/A

0DataRank · unranked

5 citations

Prasad Dandawate, Sumedha Gunewardena, Obdulia Covarrubias‐Zambrano, Katherine F. Roby, Dineo Khabele +8 more

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer

Journal of Clinical Investigation(2025)10.1172/jci189511

N/A

0DataRank · unranked

7 citations

Amanda Compadre, Rebecca Drexler, Megan Loeb, Kevin Rodriguez, Joshua Brill +22 more

The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model

BMC Cancer(2025)10.1186/s12885-025-13640-z

N/A

0DataRank · unranked

1 citations

Katherine F. Roby, Harsh B. Pathak, Andrew K. Godwin, Sumedha Gunewardena, Dineo Khabele +1 more

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2 -deficient ovarian cancer model

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.24.678351

N/A

0DataRank · unranked

0 citations

Vijayalaxmi Gupta, Bisiayo Fashemi, Moreniola Akande, Elizabeth Babu, Prasanth Thuthika +17 more